Aridis Pharmaceuticals Inc (ARDS): Aridis' Pan-Coronavirus Monoclonal A...

Reply Private New

Next 10 Prev Next

Send PM Follow Ignore

Re: None

Thursday, 02/17/2022 7:25:22 AM

Thursday, February 17, 2022 7:25:22 AM

Aridis' Pan-Coronavirus Monoclonal Antibody Cocktail AR-701 Is Protective in COVID-19 Omicron Infected Animals
Thu, February 17, 2022, 3:45 AM

Keep Last Read

Next 10 Prev Next

Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/29/2024 12:36:12 AM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/28/2024 11:46:52 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/28/2024 11:32:40 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/28/2024 11:29:41 PM
Form 8-K - Current report • Edgar (US Regulatory) • 06/27/2024 08:15:22 PM
Aridis Provides Corporate Update • GlobeNewswire Inc. • 06/24/2024 09:58:04 PM
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 01:02:49 AM
Form 8-K - Current report • Edgar (US Regulatory) • 01/16/2024 11:05:19 AM
Aridis Pharmaceuticals Announces Adjournment of Annual Meeting of Stockholders until January 12, 2024 • GlobeNewswire Inc. • 12/15/2023 09:15:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/03/2023 09:00:31 PM
Aridis Pharmaceuticals Announces Third Quarter 2023 Financial Results and Business Update • GlobeNewswire Inc. • 11/03/2023 08:15:00 PM
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 11/03/2023 10:15:10 AM

InvestorsHub NewsWire

Only $200 per official company press release!